Pancreas and Islet Allograft Failure

Patrick G. Dean, Yogish Kudva, Mark D. Stegall

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The treatment of diabetes mellitus is aimed at improving glycemic control. Establishing relatively tight control using exogenous insulin has been shown to reduce the ophthal-mologic, neurologic and renal complications of diabetes mellitus.1 However, achieving a glycosylated hemoglobin (Hgb A1C) level low enough to reduce secondary complications (a level of approximately 7.0%) is associated with an increased risk of severe, life-threatening hypoglycemia. Both whole organ pancreas transplantation and isolated islet transplantation offer the possibility of even better glycemic control (average Hgb A1C < 6.0%) with the addition of counter-regulatory feedback hormones that avoid life-threatening hypoglycemia.

Original languageEnglish (US)
Title of host publicationChronic Allograft Failure
Subtitle of host publicationNatural History, Pathogenesis, Diagnosis and Management
PublisherCRC Press
Pages247-251
Number of pages5
ISBN (Electronic)9781498712729
ISBN (Print)9781587061530
DOIs
StatePublished - Jan 1 2008

Fingerprint

glycemic control
allografting
hypoglycemia
Hypoglycemia
pancreas
Transplantation (surgical)
Allografts
Pancreas
Medical problems
Pancreas Transplantation
Islets of Langerhans Transplantation
Glycosylated Hemoglobin A
Organ Transplantation
Diabetes Complications
diabetes mellitus
nervous system
Nervous System
diabetes
hemoglobin
Diabetes Mellitus

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Dean, P. G., Kudva, Y., & Stegall, M. D. (2008). Pancreas and Islet Allograft Failure. In Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management (pp. 247-251). CRC Press. https://doi.org/10.1201/9781498712729-40

Pancreas and Islet Allograft Failure. / Dean, Patrick G.; Kudva, Yogish; Stegall, Mark D.

Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management. CRC Press, 2008. p. 247-251.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dean, PG, Kudva, Y & Stegall, MD 2008, Pancreas and Islet Allograft Failure. in Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management. CRC Press, pp. 247-251. https://doi.org/10.1201/9781498712729-40
Dean PG, Kudva Y, Stegall MD. Pancreas and Islet Allograft Failure. In Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management. CRC Press. 2008. p. 247-251 https://doi.org/10.1201/9781498712729-40
Dean, Patrick G. ; Kudva, Yogish ; Stegall, Mark D. / Pancreas and Islet Allograft Failure. Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management. CRC Press, 2008. pp. 247-251
@inbook{24116093b8324210a0a47fb8749f28bd,
title = "Pancreas and Islet Allograft Failure",
abstract = "The treatment of diabetes mellitus is aimed at improving glycemic control. Establishing relatively tight control using exogenous insulin has been shown to reduce the ophthal-mologic, neurologic and renal complications of diabetes mellitus.1 However, achieving a glycosylated hemoglobin (Hgb A1C) level low enough to reduce secondary complications (a level of approximately 7.0{\%}) is associated with an increased risk of severe, life-threatening hypoglycemia. Both whole organ pancreas transplantation and isolated islet transplantation offer the possibility of even better glycemic control (average Hgb A1C < 6.0{\%}) with the addition of counter-regulatory feedback hormones that avoid life-threatening hypoglycemia.",
author = "Dean, {Patrick G.} and Yogish Kudva and Stegall, {Mark D.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1201/9781498712729-40",
language = "English (US)",
isbn = "9781587061530",
pages = "247--251",
booktitle = "Chronic Allograft Failure",
publisher = "CRC Press",

}

TY - CHAP

T1 - Pancreas and Islet Allograft Failure

AU - Dean, Patrick G.

AU - Kudva, Yogish

AU - Stegall, Mark D.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The treatment of diabetes mellitus is aimed at improving glycemic control. Establishing relatively tight control using exogenous insulin has been shown to reduce the ophthal-mologic, neurologic and renal complications of diabetes mellitus.1 However, achieving a glycosylated hemoglobin (Hgb A1C) level low enough to reduce secondary complications (a level of approximately 7.0%) is associated with an increased risk of severe, life-threatening hypoglycemia. Both whole organ pancreas transplantation and isolated islet transplantation offer the possibility of even better glycemic control (average Hgb A1C < 6.0%) with the addition of counter-regulatory feedback hormones that avoid life-threatening hypoglycemia.

AB - The treatment of diabetes mellitus is aimed at improving glycemic control. Establishing relatively tight control using exogenous insulin has been shown to reduce the ophthal-mologic, neurologic and renal complications of diabetes mellitus.1 However, achieving a glycosylated hemoglobin (Hgb A1C) level low enough to reduce secondary complications (a level of approximately 7.0%) is associated with an increased risk of severe, life-threatening hypoglycemia. Both whole organ pancreas transplantation and isolated islet transplantation offer the possibility of even better glycemic control (average Hgb A1C < 6.0%) with the addition of counter-regulatory feedback hormones that avoid life-threatening hypoglycemia.

UR - http://www.scopus.com/inward/record.url?scp=85075282322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075282322&partnerID=8YFLogxK

U2 - 10.1201/9781498712729-40

DO - 10.1201/9781498712729-40

M3 - Chapter

AN - SCOPUS:85075282322

SN - 9781587061530

SP - 247

EP - 251

BT - Chronic Allograft Failure

PB - CRC Press

ER -